Disclosure Of Entity's Operating Segments [Text Block]

GenSight Biologics S.A. - Filing #2816652

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
5,276,000 EUR
4,394,000 EUR
Tax expense (income)
2,000 EUR
2,000 EUR
Profit (loss)
28,617,000 EUR
28,617,000 EUR
34,015,000 EUR
34,015,000 EUR
Assets
56,648,000 EUR
47,361,000 EUR
Cash flows from (used in) operating activities
17,139,000 EUR
15,044,000 EUR
Cash flows from (used in) investing activities
16,000 EUR
376,000 EUR
Cash flows from (used in) financing activities
23,739,000 EUR
33,859,000 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.